News
Hosted on MSN2m
Vinay Prasad vs the FDA: How One Doctor's Policies Collided with Politics and Cost Him His JobGene Therapy Controversy Adds to the Fallout The scrutiny intensified following the FDA's handling of Elevidys, a gene ...
32mon MSN
Dr Vinay Prasad has resigned from the FDA after less than three months amid controversy over Sarepta Therapeutics' gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results